AlphaStar Capital Management LLC Has $2.93 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

AlphaStar Capital Management LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,490 shares of the company's stock after buying an additional 748 shares during the quarter. AlphaStar Capital Management LLC's holdings in HCA Healthcare were worth $2,934,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HCA. Atwood & Palmer Inc. bought a new stake in shares of HCA Healthcare in the first quarter valued at approximately $28,000. Bartlett & CO. Wealth Management LLC lifted its position in shares of HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares in the last quarter. ORG Partners LLC raised its holdings in shares of HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after purchasing an additional 86 shares during the period. Tidemark LLC bought a new stake in HCA Healthcare during the 4th quarter valued at $36,000. Finally, Legacy Investment Solutions LLC raised its position in shares of HCA Healthcare by 99.0% during the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after buying an additional 95 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Down 0.3%

HCA Healthcare stock traded down $1.27 during trading on Tuesday, reaching $377.71. The stock had a trading volume of 1,098,684 shares, compared to its average volume of 1,461,619. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The business has a 50 day moving average price of $372.47 and a 200 day moving average price of $340.19. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. The stock has a market cap of $90.87 billion, a PE ratio of 16.79, a P/E/G ratio of 1.30 and a beta of 1.47.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The company had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.36 earnings per share. On average, analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Stockholders of record on Monday, June 16th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.76%. The ex-dividend date was Monday, June 16th. HCA Healthcare's dividend payout ratio is currently 12.81%.

Wall Street Analysts Forecast Growth

HCA has been the subject of several recent analyst reports. Wall Street Zen raised shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday. Royal Bank Of Canada restated an "outperform" rating and issued a $404.00 target price (up previously from $376.00) on shares of HCA Healthcare in a report on Monday, June 23rd. Guggenheim started coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They issued a "neutral" rating for the company. Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the company an "equal weight" rating in a report on Monday, June 9th. Finally, Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Seven analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $395.71.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.